Muscle imaging in neuromuscular disease using computerized real‐time sonography

Asma Q. Fischer, Darrell W. Carpenter, Patricia L. Hartlage, James Edwin Carroll, Sharon Stephens

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The results of a study utilizing computerized real‐time sonography (CRS) to image muscles in patients with neuromuscular disease are presented for 67 patients, 37 with neuromuscular disease and 4 with upper motor neuron disease, and 26 age‐matched healthy controls between the ages of 2 days and 59 years. CRS is a safe, noninvasive, atraumatic method for evaluating a broad range of neuromuscular diseases. It is capable of differentiating myopathies or dystrophies from neurogenic atrophies and floppy infants with “central” hypotonia from those with neuromuscular diseases.

Original languageEnglish (US)
Pages (from-to)270-275
Number of pages6
JournalMuscle & Nerve
Volume11
Issue number3
DOIs
StatePublished - Jan 1 1988

Fingerprint

Neuromuscular Diseases
Ultrasonography
Muscles
Motor Neuron Disease
Muscle Hypotonia
Muscular Diseases
Atrophy

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Muscle imaging in neuromuscular disease using computerized real‐time sonography. / Fischer, Asma Q.; Carpenter, Darrell W.; Hartlage, Patricia L.; Carroll, James Edwin; Stephens, Sharon.

In: Muscle & Nerve, Vol. 11, No. 3, 01.01.1988, p. 270-275.

Research output: Contribution to journalArticle

Fischer, Asma Q. ; Carpenter, Darrell W. ; Hartlage, Patricia L. ; Carroll, James Edwin ; Stephens, Sharon. / Muscle imaging in neuromuscular disease using computerized real‐time sonography. In: Muscle & Nerve. 1988 ; Vol. 11, No. 3. pp. 270-275.
@article{c99e87a41fc54a139132476c50660ba9,
title = "Muscle imaging in neuromuscular disease using computerized real‐time sonography",
abstract = "The results of a study utilizing computerized real‐time sonography (CRS) to image muscles in patients with neuromuscular disease are presented for 67 patients, 37 with neuromuscular disease and 4 with upper motor neuron disease, and 26 age‐matched healthy controls between the ages of 2 days and 59 years. CRS is a safe, noninvasive, atraumatic method for evaluating a broad range of neuromuscular diseases. It is capable of differentiating myopathies or dystrophies from neurogenic atrophies and floppy infants with “central” hypotonia from those with neuromuscular diseases.",
author = "Fischer, {Asma Q.} and Carpenter, {Darrell W.} and Hartlage, {Patricia L.} and Carroll, {James Edwin} and Sharon Stephens",
year = "1988",
month = "1",
day = "1",
doi = "10.1002/mus.880110313",
language = "English (US)",
volume = "11",
pages = "270--275",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Muscle imaging in neuromuscular disease using computerized real‐time sonography

AU - Fischer, Asma Q.

AU - Carpenter, Darrell W.

AU - Hartlage, Patricia L.

AU - Carroll, James Edwin

AU - Stephens, Sharon

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The results of a study utilizing computerized real‐time sonography (CRS) to image muscles in patients with neuromuscular disease are presented for 67 patients, 37 with neuromuscular disease and 4 with upper motor neuron disease, and 26 age‐matched healthy controls between the ages of 2 days and 59 years. CRS is a safe, noninvasive, atraumatic method for evaluating a broad range of neuromuscular diseases. It is capable of differentiating myopathies or dystrophies from neurogenic atrophies and floppy infants with “central” hypotonia from those with neuromuscular diseases.

AB - The results of a study utilizing computerized real‐time sonography (CRS) to image muscles in patients with neuromuscular disease are presented for 67 patients, 37 with neuromuscular disease and 4 with upper motor neuron disease, and 26 age‐matched healthy controls between the ages of 2 days and 59 years. CRS is a safe, noninvasive, atraumatic method for evaluating a broad range of neuromuscular diseases. It is capable of differentiating myopathies or dystrophies from neurogenic atrophies and floppy infants with “central” hypotonia from those with neuromuscular diseases.

UR - http://www.scopus.com/inward/record.url?scp=0023837770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023837770&partnerID=8YFLogxK

U2 - 10.1002/mus.880110313

DO - 10.1002/mus.880110313

M3 - Article

VL - 11

SP - 270

EP - 275

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 3

ER -